![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 52, 50463-50468, December 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institut de Pharmacologie Moléculaire et Cellulaire,
CNRS-UMR6097, 660 route des Lucioles, Sophia Antipolis,
06560 Valbonne, France
Received for publication, August 29, 2002, and in revised form, October 16, 2002
Acid-sensing ion channels (ASICs) are cationic
channels activated by extracellular protons. They are expressed in
central and sensory neurons where they are involved in neuromodulation and in pain perception. Recently, the PDZ domain-containing protein PICK1 (protein interacting with C-kinase) has been shown to interact with ASIC1a and ASIC2a, raising the possibility that protein kinase C
(PKC) could regulate ASICs. We now show that the amplitude of the
ASIC2a current, which was only modestly increased (~+30%) by
the PKC activator 1-oleyl-2-acetyl-sn-glycerol (OAG, 50 µM) in the absence of PICK1, was strongly potentiated
(~+300%) in the presence of PICK1. This PICK1-dependent
regulatory effect was inhibited in the presence of a PKC inhibitory
peptide and required the PDZ domain of PICK1 as well as the PDZ-binding
domain of ASIC2a. We have also shown the direct
PICK1-dependent phosphorylation of ASIC2a by
[32P]phosphate labeling and immunoprecipitation and
identified a major phosphorylation site, 39TIR, on
the N terminus part of ASIC2a. The OAG-induced increase in ASIC2a
current amplitude did not involve any change in the unitary conductance
of the ASIC2a channel, whether co-expressed with PICK1 or not. These
data provide the first demonstration of a regulation of ASICs by
protein kinase phosphorylation and its potentiation by the
partner protein PICK1.
In sensory and central neurons, H+-activated cation
currents flowing through acid-sensing ionic channels
(ASICs)1 have been widely
recorded, showing functional and pharmacological properties depending
on the homomeric or heteromeric association of different ASIC subunits
(1, 2). Some ASIC subunits are specifically expressed in sensory
neurons, such as ASIC1b (3) and ASIC3 (4, 5), whereas ASIC1a (5-8),
ASIC2a (6, 8-11), ASIC2b (10), and ASIC4 (8, 12, 13) are also found in central neurons.
In sensory neurons, ASIC-like currents are thought to play an important
role in nociception during tissue acidosis and inflammation (2, 5, 7,
14-17), and ASIC2a has also been proposed to participate in
touch sensation (11). In the central nervous system, an important role
for ASICs in neuromodulation of the synaptic transmission has been
proposed (18). In hippocampal neurons, we have recently shown that
small pH changes, compatible with local transient acidifications
reported in the central nervous system during normal neuronal activity
(18-21), could activate an ASIC-like current and trigger a membrane
depolarization, leading to trains of action potentials (22). This
hippocampal ASIC-like current was co-activated by zinc acting on
ASIC2a-containing channels (22, 23). A role for ASICs in hippocampal
synaptic plasticity and memory processes has been proposed recently
(24). ASICs could also be involved in pathological situations such as
brain ischemia and epilepsy that both produce significant extracellular acidification (25-28).
Although ASIC currents can be recorded in virtually all types of
neuronal cells, their physiological regulation by mediators, transduction pathways, or protein kinases is unknown, although several
putative phosphorylation sites can be predicted from the ASIC protein
sequences. Recently, two PDZ domain-containing partner proteins have
been isolated by yeast two-hybrid cloning: CIPP (channel-interacting
PDZ domain-containing protein), which interacts with the ASIC3 C
terminus (29), and PICK1 (protein interacting with C-kinase), which
interacts with the ASIC1a and ASIC2a C terminus (30, 31). CIPP was
shown to increase the ASIC3 current membrane density (29), but no
functional effect of PICK1 on ASIC currents has been reported so far.
PICK1 was originally isolated by its ability to bind the C terminus of
protein kinase C (PKC) via its single PDZ domain (32-34). Although
PICK1 has only one PDZ domain, it can multimerize through its
coiled-coil region and therefore cross-link two different partners (32,
33, 35), thus providing a molecular mechanism for the targeting of PKC
to specific proteins regulated by phosphorylation. ASIC1a and ASIC2a
co-localize with PICK1 at the peripheral sensory endings of
dorsal root ganglia neurons as well as at the synapses and cell bodies
of some central neurons, such as pyramidal hippocampal neurons (30,
31).
This work analyzes the regulation of ASIC2a by PKC. It shows that the
ASIC2a current amplitude is increased by PKC phosphorylation and that
PICK1 potentialized this regulation.
Plasmid Constructions and Mutagenesis--
Mouse PICK1 coding
sequence (GenBankTM accession number NM008837; 96% amino acid identity
with rat PICK1 and identical PDZ domain) was amplified by PCR
from mouse brain cDNA, sequenced, and subcloned into the
bicistronic vector pCI-IRES-CD8 (36) for expression in COS cells. The
PICK1 Expression of PICK1 and ASIC2a in COS Cells--
COS cells, at a
density of 20,000 cells/35-mm diameter Petri dish, were transfected
using the DEAE-dextran method with a mix of pCI-rASIC2a,
pCI-rASIC2a Chemicals--
Phorbol 12,13-dibutyrate (PDBu), the
cell-permeable diacylglycerol analog
1-oleyl-2-acetyl-sn-glycerol (OAG), and protein kinase C
19-36 inhibitory peptide (PKC-I) were all from Sigma.
In Vivo Phosphorylation of ASIC2a--
P100 dishes containing 3 million COS cells were transfected with 0.5 µg of pCI-rASIC2a with or
without 5 µg of pCI-PICK1-IRES-CD8 using Exgen500 (Euromedex)
following the supplier's protocol. Cells were serum-deprived for
24 h, phosphate-deprived for 2 h, and labeled with
[32P]orthophosphate (100 µCi/ml) for 3 h. PDBu
stimulation was carried out for 20 min (2 µM). Cell
numbers in the different conditions were checked to be equivalent.
After phosphate-buffered saline wash, confluent cell layers were
scraped in TNE buffer (10 mM Tris-HCl, 150 mM
NaCl, 1 mM EDTA, protease inhibitor mixture (Roche Applied
Science), phosphatase inhibitor mixture (Sigma)). After centrifugation,
the membrane pellets were resuspended in TNEN buffer (TNE containing
1% Nonidet P-40) and sonicated. After a 30-min centrifugation at
100,000 × g, the supernatants were precleared with protein-A-Sepharose and incubated overnight at 4 °C with 1 µg
of rabbit anti-rat ASIC2a antibody (Alomone Laboratories). Protein-A-Sepharose was added for 1 h at 4 °C and then washed five times with TNEN. Immunoprecipitated proteins were boiled in SDS
buffer and separated by SDS-PAGE (8% polyacrylamide). The gel was
vacuum-dried and analyzed with a BAS-1500 Fujifilm phosphorimaging device and Tina 2.0.
Effect of PICK1 on Functional Properties and Density of ASIC2a
Current--
When co-expressed with ASIC2a, PICK1 did not
significantly modify the pH dependence of the current (Fig.
2A), the inactivation time
constant, nor the time-to-peak of the current (Table
I, lines 1 and 2).
Also, the ASIC2a current density was not increased in the presence of
PICK1 (Fig. 2B), unlike the situation observed with
ASIC3 after its interaction with another PDZ domain-containing partner
protein CIPP (29). A slight decrease of the ASIC2a current density was
observed in the presence of PICK1 (27 ± 3 pA/pF versus 33 ± 5 pA/pF with and without PICK1, respectively), but it was not significant (p = 0.30).
PICK1 Potentiation of the OAG-induced Stimulation of ASIC2a
Current--
When 50 µM OAG, the cell-permeable analog
of the endogenous PKC activator diacylglycerol, was applied
extracellularly, it induced a 1.35 ± 0.08-fold (n = 12) increase of ASIC2a current amplitude (Fig.
3, A ( PICK1 Interaction with ASIC2a through Its PDZ Domain--
The
interaction between PICK1 and ASIC2a was found to require the PDZ
domain of PICK1 and the last four amino acids of ASIC2a (30, 31). When
PICK1 was co-expressed with ASIC2a PICK1-dependent PKC-induced Phosphorylation of
ASIC2a--
To specifically inhibit PKC, we used the 19-36 PKC
peptide (PKC-I), acting as a pseudosubstrate on the active site of PKC (38). In the presence of this PKC-I (50 µM), in the
pipette solution, the OAG-induced increase of ASIC2a current in
the presence of PICK1 was reduced to a 1.56 ± 0.23-fold increase
(n = 8, Fig. 3B, bar 6, not
significantly different from the basal variations of ASIC2a current,
p = 0.08), thus showing the specific involvement of PKC
in the effect of PICK1-dependent OAG-induced stimulation of
ASIC2a current. An analysis of the ASIC2a sequence revealed a putative
PKC phosphorylation site, 39TIR, matching the
conventional consensus (S/T)*X(K/R) motif (single amino acid codes with X corresponding to any amino acid and
* corresponding to the phosphorylated amino acid) (39) in the cytoplasmic N terminus fragment, just before the first transmembrane domain. The ASIC2aT39G and ASIC2aT39D mutants produced currents similar
to wild-type ASIC2a, but the OAG effect in the presence of PICK1 was
greatly reduced to 1.68 ± 0.30-fold (n =
11) and 1.18 ± 0.90-fold (n = 6),
respectively (Fig. 3B, bars 7 and 8), which was not significantly different from the OAG-induced increase of
ASIC2a current in the absence of PICK1 (1.35 ± 0.08, Fig.
3B, bar 2; p = 0.27 and
p = 0.23, respectively). Neither was significantly different from the basal variations of ASIC2a current (bar
1; p = 0.14 and p = 0.41, respectively). The OAG-induced increases in ASIC2aT39G and ASIC2aT39D
current amplitudes were not significantly different (p = 0.4). The kinetics of the two ASIC2a mutants co-expressed with PICK1
were not significantly different (p > 0.05) from those of ASIC2a and were not affected by the OAG treatment (Table I, lines 5 and 6).
In the ASIC2aT39D mutant, one could expect that the aspartic residue
mimics a phosphorylated threonine, thus constitutively stimulating the
current. The mean current density of the ASIC2aT39D mutant expressed
with PICK1 (40.93 ± 12.49 pA/pF, n = 14) was slightly higher but not significantly different from the mean current
density of the ASIC2a current expressed with PICK1 (26.53 ± 3.37 pA/pF, n = 59, p = 0.12). As we do not
know whether the cellular expressions are similar for the wild-type and
the mutated channel, it is thus difficult to postulate upon the fact
that the T39D mutation mimics a phosphorylated residue. The inhibition of the PICK1-dependent OAG-induced increase of the ASIC2a
current by both the T39D and the T39G mutations shows that the
39TIR site is necessary for the OAG-induced increase of
ASIC2a current and strongly suggests a direct phosphorylation of ASIC2a
by PKC.
To determine whether ASIC2a was directly phosphorylated by PKC, we
performed an in vivo [32P]phosphate labeling
and immunoprecipitation on ASIC2a-transfected cells with or without
PICK1 after treatment with PDBu (2 µM, 20 min). A typical
experiment is shown in Fig. 3D. There is a small basal
phosphorylation of ASIC2a (Fig. 3D, lane 3),
which is unchanged by the PKC activator PDBu (Fig. 3D,
lane 4). When ASIC2a is co-transfected with PICK1 cDNA,
ASIC2a phosphorylation markedly increases when cells are treated with
PDBu (~4-fold increase, Fig. 3D, lanes 1-2).
Effect of PICK1 and OAG Treatment on ASIC2a Unitary Channel
Conductance--
We recorded ASIC2a channels in outside-out patches
from COS cells expressing ASIC2a channels (Fig.
4A), ASIC2a channels
co-expressed with PICK1 (Fig. 4B), and ASIC2a channels
co-expressed with PICK1 after a 10-min treatment by 50 µM
OAG (Fig. 4C). The outside-out mode recording was necessary
to activate the channels by an extracellular pH drop but prevented the
comparison of the channel activity before and after OAG-induced PKC
activation on the same membrane patch. ASIC2a channels were activated
by a small pH drop to pH 6 or pH 5.5 to limit the channel activity and
allow the measurement of single openings. Fig. 4 shows that neither the
PICK1 co-expression nor the OAG treatment in the presence of PICK1
increases the channel conductance (10.93 ± 1.22 picosiemens between This study provides the first evidence for a regulation of an ASIC
current by a protein kinase and for a potentiation of this regulation
by a partner protein. It shows that the amplitude of the ASIC2a current
is increased by PKC phosphorylation and that PICK1 is required for a
potent activation (a factor of 3.9-fold), probably by allowing an
optimal interaction between the kinase and its target channel. We
demonstrate the involvement of the PDZ domain of PICK1 and of the
PDZ-binding domain of ASIC2a in this regulatory effect and identify
39TIR as a major phosphorylation site. Indeed, the
PICK1-dependent OAG-induced increase of the ASIC2a current
was highly reduced by the T39D and T39G mutations. However, it is not
clear whether the T39D mutation mimics a phosphorylation of the
threonine residue, thus constitutively stimulating the current, as the
mean current density of the ASIC2aT39D mutant is not significantly
different from that of ASIC2a. In vivo phosphorylation
experiments confirm that PKC activation induces phosphorylation of
ASIC2a in the presence of PICK1 (Fig. 3D) and correlates
well with patch clamp experiments. The PICK1-dependent
PKC-induced phosphorylation does not change the kinetics, pH
dependence, and unitary conductance of ASIC2a channels but probably
induces an increase of the channel open probability.
The other known partner protein for ASICs isolated by yeast two-hybrid
experiments is CIPP, another PDZ domain-containing protein (29). Unlike
PICK1 (30, 31) for ASIC2a, cotransfection with CIPP increases the ASIC3
current membrane density and produces a shift in the
pH-dependent activation. The cystic fibrosis
transmembrane conductance regulator (CFTR) has also been shown to
regulate ASICs; however, the physiological relevance of this regulation
is not known (40).
ASIC2a was described to co-localize with PICK1 both at peripheral
sensory endings of dorsal root ganglia neurons as well as at synapses
and cell bodies of some central neurons (30, 31). On both central and
sensory neurons, native ASIC-like currents are now well characterized,
particularly their pH sensitivities and their effect on membrane
excitability (5, 22, 41-45). There is evidence concerning their
physiological involvement in hippocampal synaptic plasticity (24),
inflammatory pain (5, 46), and hypoxia-induced cardiac pain (16, 17).
The PICK1-dependent regulation of ASICs by PKC would thus
further support the involvement of these H+-gated channels
in synaptic plasticity and peripheral sensitization processes.
There is considerable evidence for the PKC-dependent
central modulation of neurotransmission and synaptic plasticity
processes (47-50). PKC activation causes an increase in both the
amplitude and the frequency of miniature excitatory postsynaptic
elements in hippocampal CA1 neurons (51, 52) and potentiates synaptic transmission in spinal neurons (53). In peripheral sensory
neurons, PKC also plays a key role in peripheral sensitization of
nociceptors induced by neuropeptides and inflammatory mediators
(54-56). The PDZ domain-containing protein PICK1 is expressed at
central synapses where it regulates the localization of channels,
receptors, and transporters. The GluR2 subunit from the
We have shown that ASIC2a is regulated by PKC through interaction with
its partner protein PICK1. This result is an important step toward a
better understanding of the physiological involvement of ASICs in
pain sensing and neurotransmission.
We thank M. Jodar, N. Leroudier, and V. Friend for excellent technical assistance and V. Lopez for secretarial assistance.
*
This work was supported by the Centre National de la
Recherche Scientifique (CNRS), the Institut National de la Santé
et de la Recherche Médicale (INSERM), the Ministère de la
Recherche (ACI, Molécules et Cibles Thérapeutiques), the
Association Française contre les Myopathies (AFM), the
Association pour la Recherche sur le Cancer (ARC) and the AstraZenecaAB
Research Area Central Nervous System/Pain.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.:
33-4-93-95-77-02 or 03; Fax: 33-4-93-95-77-04; E-mail:
ipmc@ipmc.cnrs.fr.
Published, JBC Papers in Press, October 23, 2002, DOI 10.1074/jbc.M208848200
The abbreviations used are:
ASIC, acid
sensing ion channel;
PICK1, protein interacting with C-kinase;
MES, 4-morpholinoethanesulfonic acid;
OAG, 1-oleyl-2-acetyl-sn-glycerol;
PDBu, phorbol 12, 13-dibutyrate;
PKC, protein kinase C;
PKC-I, PKC inhibitory peptide;
CIPP, channel-interacting PDZ domain-containing protein;
pF, picofarads.
Protein Kinase C Stimulates the Acid-sensing Ion Channel ASIC2a
via the PDZ Domain-containing Protein PICK1*
,
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
PDZ mutant was obtained by replacing the
27KD28 residues by two alanines in the PDZ
domain (35). The rat ASIC2a coding sequence (GenBankTM accession number
U53211) was subcloned into pCI vector (Promega) for expression in COS
cells. The potential PKC phosphorylation site, 39TIR, was
suppressed by the introduction of the T39G or T39D point mutations.
In another mutant, named ASIC2a
C, the C-terminal PDZ-binding domain was suppressed by deletion of the last three residues (30, 31).
Point mutations and deletions of rASIC2a and mPICK1 were performed by
PCR strategies and entirely sequenced. ASIC2a and PICK1 wild-type and
mutant proteins corresponding to the cDNAs used in the present work
are schematically described in Fig.
1.

View larger version (25K):
[in a new window]
Fig. 1.
Schematic representation of
ASIC2a and PICK1 wild-type and mutant proteins. In A,
the ASIC2a protein displays two transmembrane domains (TM1
and TM2) with a cytoplasmic N and C terminus and a large
extracellular loop. The last three amino acids of the protein
correspond to the PDZ-interacting domain, which have been deleted in
the mutant ASIC2a
C. A PKC phosphorylation site, 39TIR,
was predicted in the N-terminal domain of ASIC2a and mutated in
ASIC2aT39G and ASIC2aT39D mutants. As shown in B, PICK1
contains a large PDZ domain implicated in the interaction with
the C terminus of ASIC2a and a coiled-coil domain that is responsible
for the protein dimerization. In the mutant PICK1
PDZ, the two amino
acids Lys-27 and Asp-28, which are critical in the PDZ domain, have
been mutated to Ala.
C, pCI-rASIC2aT39G, pCI-rASIC2aT39D with pCI-IRES-CD8,
pCI-PICK1-IRES-CD8, pCI-PICK1
PDZ-IRES-CD8 (1:10 ratio). Cells were
used for electrophysiological measurements for 1-3 days after
transfection. Successfully transfected cells were recognized by their
ability to fix CD8 antibody-coated beads (Dynal A. S., Oslo, Norway).
Ion currents were recorded using the whole cell and the outside-out
modes of the patch clamp technique (37). Data were sampled at either
500 Hz or 10 kHz for whole cell and outside-out recordings,
respectively, and low pass-filtered at 3 kHz using the pClamp8 software
(Axon Instruments, Foster City, CA). Off-line low pass 1-kHz gaussian
filtering and analysis of currents were performed using pClamp
(Axon Instruments, Foster City, CA). The statistical significance of
differences between sets of data was estimated by the Student's
t test. The pipette solution contained 140 mM
KCl, 5 mM NaCl, 2 mM MgCl2, 5 mM EGTA, 10 mM HEPES (pH 7.3), and the bath
solution contained 150 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2,
10 mM HEPES (pH 7.4). MES or acetate was used instead of
HEPES to buffer the bath solution pH ranging from 6 to 5 and from 4.5 to 3, respectively. Changes in extracellular pH were induced by
shifting one out of eight outlets of a microperfusion system in front
of the cell. Experiments were carried out at room temperature
(20-22 °C).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 2.
Effect of PICK1 on ASIC2a pH dependence and
current density. A, pH dependence of ASIC2a currents
recorded from COS-transfected cells at
50 mV in the presence (
) or
the absence (
) of PICK1. Sigmoidal dose-response curves were used to
fit the data. The slope factor was 1.65, pH0.5 = 4.44 ± 0.08 and pH0.5 = 4.36 ± 0.01, with and without
PICK1, respectively (n = 6-27). B, effect
of PICK1 expression on pH 5-evoked ASIC2a current densities measured at
50 mV (n = 59 and 20 with (
) and without (
)
PICK1, respectively. n.s., not significant;
p = 0.30, Student's t test).
Effects of PICK1 and OAG treatment on ASIC2a current kinetics
)
values were determined by mono-exponential fits of the currents in
control and after OAG treatment (10 min, 50 µM). The
statistical significance of differences between control and OAG-treated
data was estimated by the Student t-test, and p values were
given.
) and B
(bar 2)), significantly different from the basal variation
of ASIC2a current amplitude (0.98 ± 0.08, n = 5, Fig. 3B, bar 1,
; p < 0.05).
This effect was strongly potentiated in the presence of PICK1 with a
3.90 ± 0.54-fold increase (n = 20) of the ASIC2a
current induced by OAG (50 µM) (Fig. 3, A
(
) and B (bar 3, *; p < 0.05)). Similar results were obtained when the phorbol ester PDBu (2 µM) was used instead of OAG to stimulate PKC (not shown).
Fig. 3C shows that the OAG-induced increase of the
ASIC2a current in the presence of PICK1 was dependent on
the initial ASIC2a current density. The lower the current density, the
greater the OAG-induced increase factor. The OAG treatment did not
significantly modify the ASIC2a current kinetics, whether co-expressed
with PICK1 or not (Table I, lines 1 and 2).

View larger version (26K):
[in a new window]
Fig. 3.
PKC-induced stimulation of ASIC2a current via
PICK1 interaction. A, effect of 50 µM OAG
on pH 5-evoked ASIC2a current amplitudes recorded at
50 mV from two
different COS cells expressing (
) or not expressing (
) PICK1.
Currents were elicited every 2 min, and their amplitudes were
normalized to those measured before the application of OAG (I/I
control). Increase factors were plotted as a function of time. The
application of OAG is indicated by the black bar, and the
dashed line represents the no-effect level. The current
traces represented above correspond to ASIC2a currents recorded before
(a and c), and after (b and
d) the application of OAG, in the presence (a and
b) and in the absence (c and d) of
PICK1. The dotted lines represent the zero current level.
B, basal pH 5-evoked ASIC2a current amplitude variation over
a 10-min time lapse (bar 1) and increase factors of pH
5-evoked ASIC2a current amplitudes induced by a 10-12-min exposure of
the cells to OAG 50 µM (bars 2-7). Each
bar corresponds to a specific condition of transfection:
bar 1, ASIC2a; bar 2, ASIC2a; bar 3,
ASIC2a + PICK1; bar 4, ASIC2a
C+ PICK1; bar 5,
ASIC2a + PICK1
PDZ; bar 6, ASIC2a + PICK1 in presence of
the PKC-I; bar 7, ASIC2aT39G + PICK1; bar 8,
ASIC2aT39D + PICK1 (n = 5-20,
; p < 0.05 ,as compared with bar 1, *; p < 0.05, as compared with bar 2, Student's t test).
In C, the OAG-induced increase factor of pH 5-evoked ASIC2a
current amplitude, measured in the presence (
) and in the absence
(
) of PICK1, is represented as a function of initial ASIC2a current
density (before the application of OAG). D,
PICK1-dependent in vivo phosphorylation of
ASIC2a. The arrow on the left side of the
presented SDS-PAGE gel indicates the expected size of ASIC2a (80 kDa,
according to the Western blotting of rat brain membranes shown on the
supplier's technical note and Alvarez de la Rosa et al.
(72)). ASIC2a phosphorylation level was tested with (lanes
1-2) or without (lanes 3-4) PICK1 co-expression and
with (lanes 2 and 4) or without (lanes
1 and 3) a 20-min treatment by PDBu (2 µM). An equivalent protein amount was loaded for all
conditions.
C or when PICK1
PDZ was
co-expressed with ASIC2a, the OAG-induced increase of ASIC2a current
(1.46 ± 0.17-fold, n = 5, and 1.55 ± 0.20-fold, n = 6, Fig. 3B, bars
4 and 5, respectively) was not significantly different
from the OAG effect on ASIC2a without PICK1 (1.35 ± 0.08, n = 12, Fig. 3B, bar 2) but
still significantly different from the basal variations of ASIC2a
current level (
; p < 0.05). This suggests that the
direct association of the C terminus of ASIC2a with the PDZ domain of
PICK1 is necessary for the full OAG-induced increase of ASIC2a current,
even if a small part of the OAG effect remains when the association
between PICK1 and ASIC2a is disrupted. Table I (lines 3 and
4) shows that the kinetics of the ASIC2a
C + PICK1 and of
the ASIC2a + PICK1
PDZ currents are similar to those of the ASIC2a
current and are not modified by the OAG treatment.
80 and 0 mV). Taken together with results in the
Fig. 2B that do not show any PICK1-induced increase in
cellular current density, these data suggest that the
PICK1-dependent PKC-induced phosphorylation most probably increases the ASIC2a open probability rather than the number of functional channels.

View larger version (32K):
[in a new window]
Fig. 4.
Effect of PICK1 and OAG treatment on ASIC2a
unitary channel conductance. A-C, ASIC2a channels
recorded at
50 mV in three different outside-out patches from COS
cells expressing ASIC2a alone (A), ASIC2a co-expressed with
PICK1 (B), and ASIC2a co-expressed with PICK1 after a 10-min
treatment by 50 µM OAG (C). ASIC2a channels
were activated by a small pH drop to pH 6 or pH 5.5 to limit the
channel activity and allow the measurement of single openings. The
whole response to pH drop is shown as a top trace (16-s
recording), and enlargements are represented
below to show single channel openings (time intervals
corresponding to arrowheads on the whole trace).
D, unitary current amplitude expressed as a function of
membrane potential for ASIC2a (
, seven patches), ASIC2a + PICK1
(
, five patches), and ASIC2a + PICK1 after OAG treatment (
,
five patches). The ASIC2a channel conductance was estimated to
10.93 ± 1.22 picosiemens between
80 and 0 mV with a reversal
potential near +50 mV
(P

![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor
(34, 35, 57-63), the GluR3 subunit (64), the metabotropic glutamate
receptor mGluR7a (65-68), the dopamine transporter (DAT) (69), the
ERBB2/HER2 receptor (70), and the mitogen-stimulated TIS21 protein (71)
were identified previously as partners of PICK1. There is also evidence
for the involvement of PICK1 in neurotransmission and synaptic
plasticity processes. In hippocampal CA1 neurons, disruption
of the interaction between
-Amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA)
receptors and PICK1 causes an increase in basal synaptic transmission
and blocks the generation of long term depression (LTD) on a
PKC-dependent manner (59).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Both authors contributed equally to this work.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Krishtal, O. A.,
and Pidoplichko, V. I.
(1981)
Neuroscience
6,
2599-2601[CrossRef][Medline]
[Order article via Infotrieve]
2.
Waldmann, R.,
Champigny, G.,
Lingueglia, E., De,
Weille, J. R.,
Heurteaux, C.,
and Lazdunski, M.
(1999)
Ann. N. Y. Acad. Sci.
868,
67-76 3.
Chen, C. C.,
England, S.,
Akopian, A. N.,
and Wood, J. N.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10240-10245 4.
Waldmann, R.,
Bassilana, F.,
de Weille, J.,
Champigny, G.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
20975-20978 5.
Voilley, N.,
de Weille, J.,
Mamet, J.,
and Lazdunski, M.
(2001)
J. Neurosci.
21,
8026-8033 6.
Bassilana, F.,
Champigny, G.,
Waldmann, R.,
de Weille, J. R.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
28819-28822 7.
Olson, T. H.,
Riedl, M. S.,
Vulchanova, L.,
Ortiz-Gonzalez, X. R.,
and Elde, R.
(1998)
Neuroreport
9,
1109-1113[Medline]
[Order article via Infotrieve]
8.
Brockway, L. M.,
Zhou, Z. H.,
Bubien, J. K.,
Jovov, B.,
Benos, D. J.,
and Keyser, K. T.
(2002)
Am. J. Physiol.
283,
C126-C134
9.
Price, M. P.,
Snyder, P. M.,
and Welsh, M. J.
(1996)
J. Biol. Chem.
271,
7879-7882 10.
Lingueglia, E.,
de Weille, J. R.,
Bassilana, F.,
Heurteaux, C.,
Sakai, H.,
Waldmann, R.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
29778-29783 11.
Price, M. P.,
Lewin, G. R.,
McIlwrath, S. L.,
Cheng, C.,
Xie, J.,
Heppenstall, P. A.,
Stucky, C. L.,
Mannsfeldt, A. G.,
Brennan, T. J.,
Drummond, H. A.,
Qiao, J.,
Benson, C. J.,
Tarr, D. E.,
Hrstka, R. F.,
Yang, B.,
Williamson, R. A.,
and Welsh, M. J.
(2000)
Nature
407,
1007-1011[CrossRef][Medline]
[Order article via Infotrieve]
12.
Akopian, A. N.,
Chen, C. C.,
Ding, Y.,
Cesare, P.,
and Wood, J. N.
(2000)
Neuroreport
11,
2217-2222[Medline]
[Order article via Infotrieve]
13.
Grunder, S.,
Geissler, H. S.,
Bassler, E. L.,
and Ruppersberg, J. P.
(2000)
Neuroreport
11,
1607-1611[Medline]
[Order article via Infotrieve]
14.
Benson, C. J.,
Eckert, S. P.,
and McCleskey, E. W.
(1999)
Circ. Res.
84,
921-928 15.
Kress, M.,
and Zeilhofer, H. U.
(1999)
Trends Pharmacol. Sci.
20,
112-118[CrossRef][Medline]
[Order article via Infotrieve]
16.
Sutherland, S. P.,
Benson, C. J.,
Adelman, J. P.,
and McCleskey, E. W.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
711-716 17.
Sutherland, S. P.,
Cook, S. P.,
and McCleskey, E. W.
(2000)
Prog. Brain Res.
129,
21-38[Medline]
[Order article via Infotrieve]
18.
Krishtal, O. A.,
Osipchuk, Y. V.,
Shelest, T. N.,
and Smirnoff, S. V.
(1987)
Brain Res.
436,
352-356[CrossRef][Medline]
[Order article via Infotrieve]
19.
Chesler, M.,
and Kaila, K.
(1992)
Trends Neurosci.
15,
396-402[CrossRef][Medline]
[Order article via Infotrieve]
20.
Miesenbock, G., De,
Angelis, D. A.,
and Rothman, J. E.
(1998)
Nature
394,
192-195[CrossRef][Medline]
[Order article via Infotrieve]
21.
Jarolimek, W.,
Misgeld, U.,
and Lux, H. D.
(1989)
Brain Res.
505,
225-232[CrossRef][Medline]
[Order article via Infotrieve]
22.
Baron, A.,
Waldmann, R.,
and Lazdunski, M.
(2002)
J. Physiol. (Lond.)
539,
485-494 23.
Baron, A.,
Schaefer, L.,
Lingueglia, E.,
Champigny, G.,
and Lazdunski, M.
(2001)
J. Biol. Chem.
276,
35361-35367 24.
Wemmie, J. A.,
Chen, J.,
Askwith, C. C.,
Hruska-Hageman, A. M.,
Price, M. P.,
Nolan, B. C.,
Yoder, P. G.,
Lamani, E.,
Hoshi, T.,
Freeman, J. H., Jr.,
and Welsh, M. J.
(2002)
Neuron
34,
463-477[CrossRef][Medline]
[Order article via Infotrieve]
25.
Ohno, M.,
Obrenovitch, T. P.,
Hartell, N.,
Barratt, S.,
Bachelard, H. S.,
and Symon, L.
(1989)
Neurol. Res.
11,
153-159[Medline]
[Order article via Infotrieve]
26.
Nedergaard, M.,
Kraig, R. P.,
Tanabe, J.,
and Pulsinelli, W. A.
(1991)
Am. J. Physiol.
260,
R581-R588[Medline]
[Order article via Infotrieve]
27.
Johnson, M. B.,
Jin, K.,
Minami, M.,
Chen, D.,
and Simon, R. P.
(2001)
J. Cereb. Blood Flow Metab.
21,
734-740[CrossRef][Medline]
[Order article via Infotrieve]
28.
Biagini, G.,
Babinski, K.,
Avoli, M.,
Marcinkiewicz, M.,
and Seguela, P.
(2001)
Neurobiol. Dis.
8,
45-58[CrossRef][Medline]
[Order article via Infotrieve]
29.
Anzai, N.,
Deval, E.,
Schaefer, L.,
Friend, V.,
Lazdunski, M.,
and Lingueglia, E.
(2002)
J. Biol. Chem.
277,
16655-16661 30.
Duggan, A.,
Garcia-Anoveros, J.,
and Corey, D. P.
(2002)
J. Biol. Chem.
277,
5203-5208 31.
Hruska-Hageman, A. M.,
Wemmie, J. A.,
Price, M. P.,
and Welsh, M. J.
(2002)
Biochem. J.
361,
443-450[CrossRef][Medline]
[Order article via Infotrieve]
32.
Staudinger, J., Lu, J.,
and Olson, E. N.
(1997)
J. Biol. Chem.
272,
32019-32024 33.
Staudinger, J.,
Zhou, J.,
Burgess, R.,
Elledge, S. J.,
and Olson, E. N.
(1995)
J. Cell Biol.
128,
263-271 34.
Perez, J. L.,
Khatri, L.,
Chang, C.,
Srivastava, S.,
Osten, P.,
and Ziff, E. B.
(2001)
J. Neurosci.
21,
5417-5428 35.
Xia, J.,
Zhang, X.,
Staudinger, J.,
and Huganir, R. L.
(1999)
Neuron
22,
179-187[CrossRef][Medline]
[Order article via Infotrieve]
36.
Patel, A. J.,
Honore, E.,
Maingret, F.,
Lesage, F.,
Fink, M.,
Duprat, F.,
and Lazdunski, M.
(1998)
EMBO J.
17,
4283-4290[CrossRef][Medline]
[Order article via Infotrieve]
37.
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Pfluegers Arch. Eur. J. Physiol.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
38.
House, C.,
and Kemp, B. E.
(1987)
Science
238,
1726-1728 39.
Pearson, R. B.,
and Kemp, B. E.
(1991)
Methods Enzymol.
200,
62-81[Medline]
[Order article via Infotrieve]
40.
Ji, H. L.,
Jovov, B., Fu, J.,
Bishop, L. R.,
Mebane, H. C.,
Fuller, C. M.,
Stanton, B. A.,
and Benos, D. J.
(2002)
J. Biol. Chem.
277,
8395-8405 41.
Varming, T.
(1999)
Neuropharmacology
38,
1875-1881[CrossRef][Medline]
[Order article via Infotrieve]
42.
Ueno, S.,
Nakaye, T.,
and Akaike, N.
(1992)
J. Physiol. (Lond.)
447,
309-327 43.
Petruska, J. C.,
Napaporn, J.,
Johnson, R. D., Gu, J. G.,
and Cooper, B. Y.
(2000)
J. Neurophysiol.
84,
2365-2379 44.
Benson, C. J.,
Xie, J.,
Wemmie, J. A.,
Price, M. P.,
Henss, J. M.,
Welsh, M. J.,
and Snyder, P. M.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
2338-2343 45.
Bolshakov, K. V.,
Essin, K. V.,
Buldakova, S. L.,
Dorofeeva, N. A.,
Skatchkov, S. N.,
Eaton, M. J.,
Tikhonov, D. B.,
and Magazanik, L. G.
(2002)
Neuroscience
110,
723-730[CrossRef][Medline]
[Order article via Infotrieve]
46.
Steen, K. H.,
Steen, A. E.,
Kreysel, H. W.,
and Reeh, P. W.
(1996)
Pain
66,
163-170[CrossRef][Medline]
[Order article via Infotrieve]
47.
Lan, J. Y.,
Skeberdis, V. A.,
Jover, T.,
Grooms, S. Y.,
Lin, Y.,
Araneda, R. C.,
Zheng, X.,
Bennett, M. V.,
and Zukin, R. S.
(2001)
Nat. Neurosci.
4,
382-390[CrossRef][Medline]
[Order article via Infotrieve]
48.
Lovinger, D. M.,
Wong, K. L.,
Murakami, K.,
and Routtenberg, A.
(1987)
Brain Res.
436,
177-183[CrossRef][Medline]
[Order article via Infotrieve]
49.
Malinow, R.,
Madison, D. V.,
and Tsien, R. W.
(1988)
Nature
335,
820-824[CrossRef][Medline]
[Order article via Infotrieve]
50.
Wang, J. H.,
and Feng, D. P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2576-2580 51.
Parfitt, K. D.,
and Madison, D. V.
(1993)
J. Physiol. (Lond.)
471,
245-268 52.
Carroll, R. C.,
Nicoll, R. A.,
and Malenka, R. C.
(1998)
J. Neurophysiol.
80,
2797-2800 53.
Li, P.,
Kerchner, G. A.,
Sala, C.,
Wei, F.,
Huettner, J. E.,
Sheng, M.,
and Zhuo, M.
(1999)
Nat. Neurosci.
2,
972-977[CrossRef][Medline]
[Order article via Infotrieve]
54.
Julius, D.,
and Basbaum, A. I.
(2001)
Nature
413,
203-210[CrossRef][Medline]
[Order article via Infotrieve]
55.
McGuirk, S. M.,
and Dolphin, A. C.
(1992)
Neuroscience
49,
117-128[CrossRef][Medline]
[Order article via Infotrieve]
56.
Khasar, S. G.,
McCarter, G.,
and Levine, J. D.
(1999)
J. Neurophysiol.
81,
1104-1112 57.
Dev, K. K.,
Nishimune, A.,
Henley, J. M.,
and Nakanishi, S.
(1999)
Neuropharmacology
38,
635-644[CrossRef][Medline]
[Order article via Infotrieve]
58.
Xia, J.,
Chung, H. J.,
Wihler, C.,
Huganir, R. L.,
and Linden, D. J.
(2000)
Neuron
28,
499-510[CrossRef][Medline]
[Order article via Infotrieve]
59.
Daw, M. I.,
Chittajallu, R.,
Bortolotto, Z. A.,
Dev, K. K.,
Duprat, F.,
Henley, J. M.,
Collingridge, G. L.,
and Isaac, J. T.
(2000)
Neuron
28,
873-886[CrossRef][Medline]
[Order article via Infotrieve]
60.
Osten, P.,
Khatri, L.,
Perez, J. L.,
Kohr, G.,
Giese, G.,
Daly, C.,
Schulz, T. W.,
Wensky, A.,
Lee, L. M.,
and Ziff, E. B.
(2000)
Neuron
27,
313-325[CrossRef][Medline]
[Order article via Infotrieve]
61.
Kim, C. H.,
Chung, H. J.,
Lee, H. K.,
and Huganir, R. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11725-11730 62.
Iwakura, Y.,
Nagano, T.,
Kawamura, M.,
Horikawa, H.,
Ibaraki, K.,
Takei, N.,
and Nawa, H.
(2001)
J. Biol. Chem.
276,
40025-40032 63.
Braithwaite, S. P.,
Xia, H.,
and Malenka, R. C.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
7096-7101 64.
Hirbec, H.,
Perestenko, O.,
Nishimune, A.,
Meyer, G.,
Nakanishi, S.,
Henley, J. M.,
and Dev, K. K.
(2002)
J. Biol. Chem.
277,
15221-15224 65.
Dev, K. K.,
Nakajima, Y.,
Kitano, J.,
Braithwaite, S. P.,
Henley, J. M.,
and Nakanishi, S.
(2000)
J. Neurosci.
20,
7252-7527 66.
Boudin, H.,
Doan, A.,
Xia, J.,
Shigemoto, R.,
Huganir, R. L.,
Worley, P.,
and Craig, A. M.
(2000)
Neuron
28,
485-497[CrossRef][Medline]
[Order article via Infotrieve]
67.
Boudin, H.,
and Craig, A. M.
(2001)
J. Biol. Chem.
276,
30270-30276 68.
Perroy, J., El,
Far, O.,
Bertaso, F.,
Pin, J. P.,
Betz, H.,
Bockaert, J.,
and Fagni, L.
(2002)
EMBO J.
21,
2990-2999[CrossRef][Medline]
[Order article via Infotrieve]
69.
Torres, G. E.,
Yao, W. D.,
Mohn, A. R.,
Quan, H.,
Kim, K. M.,
Levey, A. I.,
Staudinger, J.,
and Caron, M. G.
(2001)
Neuron
30,
121-134[CrossRef][Medline]
[Order article via Infotrieve]
70.
Jaulin-Bastard, F.,
Saito, H., Le,
Bivic, A.,
Ollendorff, V.,
Marchetto, S.,
Birnbaum, D.,
and Borg, J. P.
(2001)
J. Biol. Chem.
276,
15256-15263 71.
Lin, W. J.,
Chang, Y. F.,
Wang, W. L.,
and Huang, C. Y.
(2001)
Biochem. J.
354,
635-643[CrossRef][Medline]
[Order article via Infotrieve]
72.
Alvarez de la Rosa, D.,
Zhang, P.,
Shao, D.,
White, F.,
and Canessa, C. M.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
2326-2331
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Baron, N. Voilley, M. Lazdunski, and E. Lingueglia Acid Sensing Ion Channels in Dorsal Spinal Cord Neurons J. Neurosci., February 6, 2008; 28(6): 1498 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chai, M. Li, J. Lan, Z.-G. Xiong, J. A. Saugstad, and R. P. Simon A Kinase-anchoring Protein 150 and Calcineurin Are Involved in Regulation of Acid-sensing Ion Channels ASIC1a and ASIC2a J. Biol. Chem., August 3, 2007; 282(31): 22668 - 22677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joch, A. R. Ase, C. X.-Q. Chen, P. A. MacDonald, M. Kontogiannea, A. T. Corera, A. Brice, P. Seguela, and E. A. Fon Parkin-mediated Monoubiquitination of the PDZ Protein PICK1 Regulates the Activity of Acid-sensing Ion Channels Mol. Biol. Cell, August 1, 2007; 18(8): 3105 - 3118. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chanrion, C. Mannoury la Cour, F. Bertaso, M. Lerner-Natoli, M. Freissmuth, M. J. Millan, J. Bockaert, and P. Marin From the Cover: Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity PNAS, May 8, 2007; 104(19): 8119 - 8124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yagi, H. N. Wenk, L. A. Naves, and E. W. McCleskey Sustained Currents Through ASIC3 Ion Channels at the Modest pH Changes That Occur During Myocardial Ischemia Circ. Res., September 1, 2006; 99(5): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, B. Duan, H. Xu, L. Xu, and T.-L. Xu Calcium-permeable Acid-sensing Ion Channel Is a Molecular Target of the Neurotoxic Metal Ion Lead J. Biol. Chem., February 3, 2006; 281(5): 2497 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salinas, L. D. Rash, A. Baron, G. Lambeau, P. Escoubas, and M. Lazdunski The receptor site of the spider toxin PcTx1 on the proton-gated cation channel ASIC1a J. Physiol., January 15, 2006; 570(2): 339 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |